Ainos, Inc. Files Q3 2024 10-Q Report
Ticker: AIMDW · Form: 10-Q · Filed: Nov 6, 2024 · CIK: 1014763
| Field | Detail |
|---|---|
| Company | Ainos, INC. (AIMDW) |
| Form Type | 10-Q |
| Filed Date | Nov 6, 2024 |
| Risk Level | medium |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, pharmaceuticals, financial-report
TL;DR
Ainos Inc. 10-Q filed Nov 6, 2024 for Q3 ending Sep 30, 2024. Pharma prep biz.
AI Summary
Ainos, Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as Amarillo Biosciences Inc., is in the pharmaceutical preparations industry. Key financial data and business addresses are provided, with the filing date being November 6, 2024.
Why It Matters
This filing provides investors and stakeholders with the latest financial performance and operational details for Ainos, Inc. during the third quarter of 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Ainos, Inc. faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 20240930 — Reporting Period End (The end date for the financial reporting period covered by this 10-Q.)
- 20241106 — Filing Date (The date the 10-Q was officially filed with the SEC.)
Key Players & Entities
- Ainos, Inc. (company) — Filer and company name
- Amarillo Biosciences Inc. (company) — Former company name
- 20240930 (date) — Reporting period end date
- 20241106 (date) — Filing date
- 858-869-2986 (phone_number) — Business phone number
FAQ
What is the primary business of Ainos, Inc.?
Ainos, Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its SIC code [2834].
When was the company formerly known as Ainos, Inc.?
The company was formerly known as Amarillo Biosciences Inc., with a date of name change on May 16, 1996.
What is the fiscal year end for Ainos, Inc.?
The fiscal year end for Ainos, Inc. is December 31.
Where is Ainos, Inc. located?
Ainos, Inc. is located at 8880 Rio San Diego Drive, Suite 800, San Diego, CA 92108.
What is the SEC file number for Ainos, Inc.?
The SEC file number for Ainos, Inc. is 001-41461.
Filing Stats: 4,615 words · 18 min read · ~15 pages · Grade level 19.6 · Accepted 2024-11-06 16:15:31
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share AIMD The Nasdaq Stock Mar
Filing Documents
- form10-q.htm (10-Q) — 986KB
- ex31-1.htm (EX-31.1) — 11KB
- ex31-2.htm (EX-31.2) — 11KB
- ex32-1.htm (EX-32.1) — 7KB
- ex32-2.htm (EX-32.2) — 7KB
- 0001493152-24-043832.txt ( ) — 4730KB
- aimd-20240930.xsd (EX-101.SCH) — 36KB
- aimd-20240930_cal.xml (EX-101.CAL) — 48KB
- aimd-20240930_def.xml (EX-101.DEF) — 178KB
- aimd-20240930_lab.xml (EX-101.LAB) — 299KB
- aimd-20240930_pre.xml (EX-101.PRE) — 244KB
- form10-q_htm.xml (XML) — 607KB
Financial Statements
Financial Statements 3 Condensed Balance Sheets– September 30, 2024 and December 31, 2023 (unaudited) 3 Condensed Statements of Operations – Three and Nine Months Ended September 30, 2024 and 2023 (unaudited) 4 Condensed Statements of Comprehensive Loss – Three and Nine Months Ended September 30, 2024 and 2023 (unaudited) 5 Condensed Statements of Stockholders' Equity– Three Months Ended September 30, 2024 and 2023 (unaudited) 6 Condensed Statements of Stockholders' Equity– Nine Months Ended September 30, 2024 and 2023 (unaudited) 7 Condensed Statements of Cash Flows – Nine Months Ended September 30, 2024 and 2023 (unaudited) 8 Notes to Condensed Financial Statements (unaudited) 9 ITEM 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 21 ITEM 3.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 28 ITEM 4.
Controls and Procedures
Controls and Procedures 28 PART II: OTHER INFORMATION ITEM 1.
Legal Proceedings
Legal Proceedings 28 ITEM 1A
Risk Factors
Risk Factors 28 ITEM 2. Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities 28 ITEM 3. Defaults Upon Senior Securities 29 ITEM 4. Mine Safety Disclosures 29 ITEM 5. Other Information 29 ITEM 6. Exhibits 29
Signatures
Signatures 30 2 PART I - FINANCIAL INFORMATION ITEM 1. Financial Statements Ainos, Inc. Condensed Balance Sheets (Unaudited) September 30, 2024 December 31, 2023 Assets Current assets: Cash and cash equivalents $ 5,156,606 $ 1,885,628 Accounts receivable - 455 Inventory, net 160,701 167,593 Other current assets 331,898 419,521 Total current assets 5,649,205 2,473,197 Intangible assets, net 24,888,249 28,283,208 Property and equipment, net 649,063 876,572 Other Assets 183,229 208,827 Total assets $ 31,369,746 $ 31,841,804 Liabilities and Stockholders' Equity Current liabilities: Contract liabilities $ 110,142 $ 112,555 Convertible notes payable (including amounts of related party of $ 2,000,000 and nil as of September 30, 2024 and December 31, 2023, respectively) 3,000,000 - Other notes payable, related party 270,000 42,000 Accrued expenses and others current liabilities 750,629 1,182,283 Total current liabilities 4,130,771 1,336,838 Long term liabilities: Senior secured convertible notes measured at fair value - 2,651,556 Convertible notes payable-noncurrent (including amounts of related party of $ 9,000,000 and $ 2,000,000 as of September 30, 2024 and December 31, 2023, respectively) 9,000,000 3,000,000 Other notes payable, related party-noncurrent - 270,000 Other long-term liabilities 216,760 135,829 Total liabilities 13,347,531 7,394,223 Commitments and contingencies - - Stockholders' equity: Preferred stock, $ 0.01 par value; 50,000,000 shares authorized; none issued and outstanding as of September 30, 2024 and December 31,2023, respectively; - - Common stock, $ 0.01 par value; 300,000,000 shares authorized as of September 30, 2024 and December 31,2023; 13,813,434 and 4,677,787 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively 138,134 46,778 Common Shares to be issued 900 shares and 162,337 shares as of S